Jun 14, 2024
Listener feedback, statin eligibility and Yogi Berra,
evidence-based medicine and heterogenous treatment effects, and
MRAs in HF are the topics John Mandrola, MD, discusses in this
week’s podcast.
This podcast is intended for healthcare professionals
only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Listener Feedback
- ASPIRE AF
https://classic.clinicaltrials.gov/ct2/show/NCT03968393
- Butala paper: Stroke After TAVR With and Without
EPD
https://www.ahajournals.org/doi/abs/10.1161/CIRCINTERVENTIONS.123.013697
- PROTECTED TAVR
- Heuts meta-analysis: EPD During TAVR
https://heart.bmj.com/content/110/11/757
II. Statin Eligibility
- JAMA-IM: Data Analytic Choices and Predicting Vascular
Events
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2819821
- Zeraatker Specification Analysis Paper
https://doi.org/10.1016/j.jclinepi.2024.111278
- PCE
https://www.mdcalc.com/calc/3398/ascvd-atherosclerotic-cardiovascular-disease-2013-risk-calculator-aha-acc
III. Heterogenous Treatment Effect
- Weisberg and Dailey-Higgs
- DANISH
IV. Heart Failure and
MRAs
- RALES
https://www.nejm.org/doi/full/10.1056/NEJM199909023411001
- EMPHASIS
https://www.nejm.org/doi/full/10.1056/NEJMoa1009492
- Combined analysis (Matsumoto)
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean
of Weill Cornell Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net